Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy
Saved in:
Main Authors: | Sjoerd H van der Burg, Ilina Ehsan, Mariette I E van Poelgeest, Dana A M Mustafa, Helena C van Doorn, Kim E Kortekaas, Saskia J Santegoets, Liselotte Tas, Pornpimol Charoentong |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a1025a5a3f4948c98a290b15cf047a5e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
by: A. N. Niemeijer, et al.
Published: (2018) -
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma
by: Alexander H. Lee, et al.
Published: (2021) -
Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer
by: Nitin Roper, et al.
Published: (2021) -
Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors
by: Sarah J. Dart, et al.
Published: (2021) -
Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
by: Chunyi Shen, et al.
Published: (2021)